Because Zepbound is the only FDA-approved medication for OSA, some BCBS plans are more likely to cover Zepbound when it's prescribed for that condition
Phentermine served its purpose for decades and continues to serve it for patients who need an affordable, fast-acting option for modest weight loss
Save on diabetes meds and supplies Bottom line Experiencing an injection site reaction usually isnt cause for alarm or a sign that you need to switch to a different medication
However, it: Only results in modest weight loss (~5-7% body weight) Can cause gastrointestinal distress (diarrhea, nausea) Works best for those with insulin resistance rather than general obesity How GLP-1 and GIP Medications Offer Superior Weight Loss GLP-1 (Glucagon-Like Peptide-1) and GIP (Gastric Inhibitory Polypeptide) receptor agonists represent a new era in obesity treatment , working through multiple mechanisms to promote substantial and sustainable weight loss : Enhanced Appetite Suppression and Fullness GLP-1/GIP medications mimic natural gut hormones that regulate hunger and satiety, leading to: Significantly reduced appetite and cravings Longer-lasting fullness after meals No stimulant effects or addiction potential More Effective Weight Loss Compared to older medications, GLP-1 and GIP drugs produce greater and sustained weight loss : Tirzepatide (Mounjaro/Zepbound): 20-25% total body weight loss Semaglutide (Ozempic/Wegovy): 15-20% total body weight loss Phentermine & Topamax (Qsymia): 5-10% weight loss Metformin: 5-7% weight loss Long-Term Safety and Cardiometabolic Benefits Unlike Phentermine, which is only approved for short-term use , GLP-1/GIP medications are safe for long-term weight management
Acute Pancreatitis Acute pancreatitis has been observed with the use of GIP/GLP-1 receptor agonists
Tirzepatide is contraindicated for individuals with a personal or family history of thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN2)
